BURLINGTON, Mass., Nov. 12, 2010 /PRNewswire via COMTEX/ -- InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the ...

BURLINGTON, Mass., April 29 /PRNewswire/ -- InfraReDx, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its catheter-based LipiScan ...

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced it has received CE Mark approval to begin commercialization of the ...

September 2, 2010 — The US Food and Drug Administration has granted 510(k) clearance for a next-generation catheter-based coronary imaging system (LipiScan IVUS; InfraReDx Inc) to help clinicians ...

InfraReDx Inc. closed a $24.1 million equity funding round boosted by 42 existing shareholders. The Burlington, Mass.-based company develops the LipiScan IVUS device, which employs both so-called ...

Federal regulators have approved the sale of a new laser scanning system intended to locate fatty deposits in blood vessel walls that are thought to cause heart attacks. The maker, InfraReDx, a ...

Of all the tools doctors have in their belt to help patients with, those which help them make a more accurate diagnosis tend to be the most valuable.

The first multimodality coronary imaging catheter has recently received 510(k) clearance from the FDA. The LipiScan IVUS Coronary Imaging System (InfraReDx) device is the result of 10 years of ...

Please provide your email address to receive an email when new articles are posted on . TearScience introduced the LipiScan, which dynamically images the meibomian glands in high definition. The ...

BURLINGTON, Mass., May 15 InfraReDx, Inc. today announcedthat physicians at Beaumont Hospital in Royal Oak, Mich., have successfullyused its LipiScan(TM) Coronary Imaging System in a patient ...

BURLINGTON, Mass., Oct. 12 InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the completion of a $21 million equity ...

> InfraReDx has announced that new data for its LipiScan coronary imaging system was published in the journal Circulation: Cardiovascular Interventions. Near-infrared spectroscopy (NIRS) with the ...